Armata Pharmaceuticals (ARMP) Other Non Operating Income (2013 - 2026)

Armata Pharmaceuticals (ARMP) has 14 years of Other Non Operating Income data on file, last reported at -$101.1 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non Operating Income fell 2042.38% year-over-year to -$101.1 million; the trailing twelve-month figure through Mar 2026 stood at -$236.8 million (down 705.22% YoY), and the FY2025 full-year result was -$121.0 million, down 614.3% from the prior year.
• Other Non Operating Income improved to -$101.1 million in Q1 2026, from -$121.2 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $23.4 million in Q2 2024 to a low of -$121.2 million in Q4 2025.
• A 5-year average of -$13.1 million and a median of $9000.0 in 2022 frame the typical range for Other Non Operating Income.
• Peak annual rise in Other Non Operating Income reached 121540.0% in 2023, while the deepest fall reached 314500.0% in 2023.
• Tracing ARMP's Other Non Operating Income over 5 years: stood at $14000.0 in 2022, then tumbled by 168671.43% to -$23.6 million in 2023, then surged by 126.46% to $6.2 million in 2024, then slumped by 2041.38% to -$121.2 million in 2025, then gained by 16.63% to -$101.1 million in 2026.
• Business Quant data shows ARMP's Other Non Operating Income at -$101.1 million in Q1 2026, -$121.2 million in Q4 2025, and -$14.6 million in Q3 2025.